Q5TEJ8 (THMS2_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
Protein THEMIS2

Alternative name(s):
Induced by contact to basement membrane 1 protein
Short name=Protein ICB-1
Thymocyte-expressed molecule involved in selection protein 2

Gene names

Name:	THEMIS2
Synonyms:	C1orf38, ICB1

Organism

Homo sapiens (Human)

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length	643 AA.
Sequence status	Complete.
Protein existence	Evidence at transcript level

General annotation (Comments)

Function	May constitute a control point in macrophage inflammatory response, promoting LPS-induced TNF production. Ref.7
Subunit structure	When phosphorylated, interacts with LYN. Interacts with VAV1 and GRB2 By similarity.
Tissue specificity	Expressed in different endometrial adenocarcinoma cell lines and various other cell lines aprat from the prostate cell line LNCAP and the ovarian cancer cell line BG-1. Ref.5
Induction	By contact to a reconstituted basement membrane.
Post-translational modification	Phosphorylation at Tyr-632 is induced by LPS By similarity.
Sequence similarities	Belongs to the themis family.
Sequence caution	The sequence AAC16284.1 differs from that shown. Reason: Frameshift at positions 416, 469, 494, 530 and 532. The sequence BAA96464.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAB33313.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAG64201.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence CAI21769.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI21771.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI21773.1 differs from that shown. Reason: Erroneous gene model prediction.

Ontologies

Keywords
Biological process	Immunity Inflammatory response
Coding sequence diversity	Alternative splicing Polymorphism
PTM	Phosphoprotein
Technical term	Complete proteome Reference proteome
Gene Ontology (GO)
Biological process	cell adhesion Traceable author statement. Source: ProtInc inflammatory response Inferred from electronic annotation. Source: UniProtKB-KW
Complete GO annotation...

Alternative products

This entry describes 6 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 (identifier: Q5TEJ8-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 (identifier: Q5TEJ8-2)

Also known as: ICB1-beta;

The sequence of this isoform differs from the canonical sequence as follows:
     216-260: MRRTIVKIPS...EVLAWEGPFP → IFSSLRIAAT...SCPQEGPQAR
     261-643: Missing.

Note: No experimental confirmation available.

Isoform 3 (identifier: Q5TEJ8-3)

Also known as: ICB1-gamma;

The sequence of this isoform differs from the canonical sequence as follows:
     252-396: Missing.

Isoform 4 (identifier: Q5TEJ8-4)

The sequence of this isoform differs from the canonical sequence as follows:
     79-123: GYFTPLNTPQ...THRIVTEGRV → VFSSLRIAAT...SCPQEGPQAR
     124-643: Missing.

Isoform 5 (identifier: Q5TEJ8-5)

The sequence of this isoform differs from the canonical sequence as follows:
     268-396: Missing.

Note: No experimental confirmation available.

Isoform 6 (identifier: Q5TEJ8-6)

The sequence of this isoform differs from the canonical sequence as follows:
     186-381: Missing.

Note: No experimental confirmation available.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 643	643	Protein THEMIS2		PRO_0000084143
Regions
	Region	1 – 238	238	CABIT 1
	Region	239 – 514	276	CABIT 2
	Compositional bias	404 – 409	6	Poly-Glu
	Compositional bias	626 – 637	12	Asp/Glu-rich
Amino acid modifications
	Modified residue	632	1	Phosphotyrosine By similarity
Natural variations
	Alternative sequence	79 – 123	45	GYFTP…TEGRV → VFSSLRIAATRSAAQTQGED LARVHQGWLQYVQQDSCPQE GPQAR in isoform 4.		VSP_015328
	Alternative sequence	124 – 643	520	Missing in isoform 4.		VSP_015329
	Alternative sequence	186 – 381	196	Missing in isoform 6.		VSP_037966
	Alternative sequence	216 – 260	45	MRRTI…EGPFP → IFSSLRIAATRSAAQTQGED LARVHQGWLQYVQQDSCPQE GPQAR in isoform 2.		VSP_015326
	Alternative sequence	252 – 396	145	Missing in isoform 3.		VSP_015330
	Alternative sequence	261 – 643	383	Missing in isoform 2.		VSP_015327
	Alternative sequence	268 – 396	129	Missing in isoform 5.		VSP_037967
	Natural variant	431	1	V → L. Corresponds to variant rs35995543 [ dbSNP | Ensembl ].		VAR_051060
	Natural variant	511	1	K → E. Ref.2 Ref.6 Corresponds to variant rs3766400 [ dbSNP | Ensembl ].		VAR_051061
Experimental info
	Sequence conflict	451	1	L → M in AAC16284. Ref.6
	Sequence conflict	466	1	T → N in AAC16284. Ref.6
	Sequence conflict	504	1	W → R in AAC16284. Ref.6
	Sequence conflict	538	1	R → C in AAC16284. Ref.6
	Sequence conflict	584	1	A → V in AAC16284. Ref.6

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 [UniParc]. Last modified December 21, 2004. Version 1. Checksum: 1D5FA24F88D2F8EA	FASTA	643	72,049
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE 130 140 150 160 170 180 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ 190 200 210 220 230 240 VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHMRRTI VKIPSTLEVD VEDVTASSRH 250 260 270 280 290 300 VHFIKPLLLS EVLAWEGPFP LSMEILEVPE GRPIFLSPWV GSLQKGQRLC VYGLASPPWR 310 320 330 340 350 360 VLASSKGRKV PRHFLVSGGY QGKLRRRPRE FPTAYDLLGA FQPGRPLRVV ATKDCEGERE 370 380 390 400 410 420 ENPEFTSLAV GDRLEVLGPG QAHGAQGSDV DVLVCQRLSD QAGEDEEEEC KEEAESPERV 430 440 450 460 470 480 LLPFHFPGSF VEEMSDSRRY SLADLTAQFS LPCEVKVVAK DTSHPTDPLT SFLGLRLEEK 490 500 510 520 530 540 ITEPFLVVSL DSEPGMCFEI PPRWLDLTVV KAKGQPDLPE GSLPIATVEE LTDTFYYRLR 550 560 570 580 590 600 KLPACEIQAP PPRPPKNQGL SKQRRHSSEG GVKSSQVLGL QQHARLPKPK AKTLPEFIKD 610 620 630 640 GSSTYSKIPA HRKGHRPAKP QRQDLDDDEH DYEEILEQFQ KTI
	Isoform 2 (ICB1-beta) [UniParc]. Checksum: B4B5C4BFF16682D7	FASTA	260	29,118
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE 130 140 150 160 170 180 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ 190 200 210 220 230 240 VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHIFSSL RIAATRSAAQ TQGEDLARVH 250 260 QGWLQYVQQD SCPQEGPQAR
	Isoform 3 (ICB1-gamma) [UniParc]. Checksum: F87DC9EA1DF4901D	FASTA	498	56,130
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE 130 140 150 160 170 180 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ 190 200 210 220 230 240 VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHMRRTI VKIPSTLEVD VEDVTASSRH 250 260 270 280 290 300 VHFIKPLLLS ERLSDQAGED EEEECKEEAE SPERVLLPFH FPGSFVEEMS DSRRYSLADL 310 320 330 340 350 360 TAQFSLPCEV KVVAKDTSHP TDPLTSFLGL RLEEKITEPF LVVSLDSEPG MCFEIPPRWL 370 380 390 400 410 420 DLTVVKAKGQ PDLPEGSLPI ATVEELTDTF YYRLRKLPAC EIQAPPPRPP KNQGLSKQRR 430 440 450 460 470 480 HSSEGGVKSS QVLGLQQHAR LPKPKAKTLP EFIKDGSSTY SKIPAHRKGH RPAKPQRQDL 490 DDDEHDYEEI LEQFQKTI
	Isoform 4 [UniParc]. Checksum: FA37B14081402515	FASTA	123	13,628
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQVF SSLRIAATRS AAQTQGEDLA RVHQGWLQYV QQDSCPQEGP QAR
	Isoform 5 [UniParc]. Checksum: C5FA6EECF503BD9C	FASTA	514	57,943
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE 130 140 150 160 170 180 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ 190 200 210 220 230 240 VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHMRRTI VKIPSTLEVD VEDVTASSRH 250 260 270 280 290 300 VHFIKPLLLS EVLAWEGPFP LSMEILERLS DQAGEDEEEE CKEEAESPER VLLPFHFPGS 310 320 330 340 350 360 FVEEMSDSRR YSLADLTAQF SLPCEVKVVA KDTSHPTDPL TSFLGLRLEE KITEPFLVVS 370 380 390 400 410 420 LDSEPGMCFE IPPRWLDLTV VKAKGQPDLP EGSLPIATVE ELTDTFYYRL RKLPACEIQA 430 440 450 460 470 480 PPPRPPKNQG LSKQRRHSSE GGVKSSQVLG LQQHARLPKP KAKTLPEFIK DGSSTYSKIP 490 500 510 AHRKGHRPAK PQRQDLDDDE HDYEEILEQF QKTI
	Isoform 6 [UniParc]. Checksum: 5E02ACFCD1435979	FASTA	447	50,028
	10 20 30 40 50 60 MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV 70 80 90 100 110 120 VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE 130 140 150 160 170 180 GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ 190 200 210 220 230 240 VLQDPAHGAQ GSDVDVLVCQ RLSDQAGEDE EEECKEEAES PERVLLPFHF PGSFVEEMSD 250 260 270 280 290 300 SRRYSLADLT AQFSLPCEVK VVAKDTSHPT DPLTSFLGLR LEEKITEPFL VVSLDSEPGM 310 320 330 340 350 360 CFEIPPRWLD LTVVKAKGQP DLPEGSLPIA TVEELTDTFY YRLRKLPACE IQAPPPRPPK 370 380 390 400 410 420 NQGLSKQRRH SSEGGVKSSQ VLGLQQHARL PKPKAKTLPE FIKDGSSTYS KIPAHRKGHR 430 440 PAKPQRQDLD DDEHDYEEIL EQFQKTI

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Testis.
[2]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-643 (ISOFORM 5), VARIANT GLU-511. Tissue: Thymus.
[3]	"The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. , Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R. Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain.
[5]	"A novel basement membrane-induced gene identified in the human endometrial adenocarcinoma cell line HEC1B." Treeck O., Strunck E., Vollmer G. FEBS Lett. 425:426-430(1998) [PubMed: 9563507] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 112-643 (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Endometrial adenocarcinoma.
[6]	Tanaka K., Imai H., Odani T., Tachibana M., Fujita S. Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 112-643 (ISOFORM 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 143-643 (ISOFORM 2), VARIANT GLU-511. Tissue: Leukocyte.
[7]	"Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage Toll-like receptor signaling and cytokine production." Peirce M.J., Brook M., Morrice N., Snelgrove R., Begum S., Lanfrancotti A., Notley C., Hussell T., Cope A.P., Wait R. PLoS ONE 5:E11465-E11465(2010) [PubMed: 20644716] [Abstract] Cited for: FUNCTION.
+	Additional computationally mapped references.

Cross-references

Sequence databases
EMBL GenBank DDBJ	CR749321 mRNA. Translation: CAH18176.1. AK303090 mRNA. Translation: BAG64201.1. Different initiation. AK303141 mRNA. Translation: BAG64245.1. AL109927 Genomic DNA. Translation: CAI21769.1. Sequence problems. AL109927 Genomic DNA. Translation: CAI21770.1. AL109927 Genomic DNA. Translation: CAI21771.1. Sequence problems. AL109927 Genomic DNA. Translation: CAI21772.1. AL109927 Genomic DNA. Translation: CAI21773.1. Sequence problems. BC031655 mRNA. Translation: AAH31655.2. BC132692 mRNA. Translation: AAI32693.1. BC133049 mRNA. Translation: AAI33050.1. AF044895 mRNA. Translation: AAC16284.1. Frameshift. AB050854 mRNA. Translation: BAB33313.1. Different initiation. AB035482 mRNA. Translation: BAA96464.1. Different initiation.
IPI	IPI00003922. IPI00307376. IPI00470916. IPI00514477. IPI00943840. IPI00943868.
RefSeq	NP_001034566.1. NM_001039477.1. NP_001099026.1. NM_001105556.1. NP_004839.2. NM_004848.2.
UniGene	Hs.10649.
3D structure databases
ProteinModelPortal	Q5TEJ8.
ModBase	Search...
Protein-protein interaction databases
IntAct	Q5TEJ8. 2 interactions.
STRING	Q5TEJ8.
PTM databases
PhosphoSite	Q5TEJ8.
Polymorphism databases
DMDM	73920021.
Proteomic databases
PRIDE	Q5TEJ8.
Protocols and materials databases
StructuralBiologyKnowledgebase	Search...
Genome annotation databases
Ensembl	ENST00000328928; ENSP00000329862; ENSG00000130775. ENST00000373921; ENSP00000363031; ENSG00000130775.
GeneID	9473.
KEGG	hsa:9473.
UCSC	uc001boz.1. human. uc001bpa.1. human. uc001bpb.1. human. uc001bpc.2. human.
Organism-specific databases
CTD	9473.
GeneCards	GC01P028199.
HGNC	HGNC:16839. C1orf38.
HPA	HPA031096. HPA031097.
neXtProt	NX_Q5TEJ8.
PharmGKB	PA128394550.
GenAtlas	Search...
Phylogenomic databases
eggNOG	prNOG08135.
GeneTree	ENSGT00530000063770.
InParanoid	Q5TEJ8.
OMA	VATKDCE.
OrthoDB	EOG4FR0R4.
Gene expression databases
ArrayExpress	Q5TEJ8.
Bgee	Q5TEJ8.
CleanEx	HS_C1orf38.
Genevestigator	Q5TEJ8.
GermOnline	ENSG00000130775. Homo sapiens.
Family and domain databases
ProtoNet	Search...
Other
NextBio	35498.

Entry information

Entry name

THMS2_HUMAN

Accession

Primary (citable) accession number: Q5TEJ8
Secondary accession number(s): A2RTZ3 , B4DZT9, B4DZY3, O60560, Q5TEJ1, Q5TEJ9, Q5TEK1, Q68DP4, Q9BYB6, Q9NS90

Entry history

Integrated into UniProtKB/Swiss-Prot:	August 30, 2005
Last sequence update:	December 21, 2004
Last modified:	January 25, 2012
This is version 60 of the entry and version 1 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.